TCOK
ABBV icon

Trust Company of Kansas’s AbbVie ABBV Stock Holding History

Trust Company of Kansas’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$505K Buy
2,008
+222
+12% +$47.8K 0.26% 30
2026
Q1 		$388K Sell
1,786
-325
-15% -$72.1K 0.21% 35
2025
Q4 		$482K Hold
2,111
– – 0.22% 32
2025
Q3 		$489K Hold
2,111
– – 0.23% 34
2025
Q2 		$392K Sell
2,111
-300
-12% -$55.8K 0.19% 38
2025
Q1 		$505K Buy
2,411
+300
+14% +$58.3K 0.27% 29
2024
Q4 		$375K Sell
2,111
-67
-3% -$12.3K 0.18% 37
2024
Q3 		$430K Sell
2,178
-10
-0.5% -$1.87K 0.21% 39
2024
Q2 		$375K Buy
2,188
+91
+4% +$15.1K 0.2% 36
2024
Q1 		$382K Sell
2,097
-100
-5% -$17.2K 0.21% 33
2023
Q4 		$340K Sell
2,197
-40
-2% -$5.83K 0.19% 35
2023
Q3 		$333K Buy
2,237
+201
+10% +$29.5K 0.21% 36
2023
Q2 		$274K Sell
2,036
-110
-5% -$16.1K 0.16% 39
2023
Q1 		$342K Sell
2,146
-208
-9% -$31.8K 0.22% 34
2022
Q4 		$380K Sell
2,354
-337
-13% -$51.7K 0.25% 38
2022
Q3 		$361K Sell
2,691
-261
-9% -$37.5K 0.26% 32
2022
Q2 		$452K Sell
2,952
-20
-0.7% -$3.06K 0.27% 30
2022
Q1 		$482K Sell
2,972
-35
-1% -$5.08K 0.26% 34
2021
Q4 		$407K Sell
3,007
-185
-6% -$21.9K 0.22% 39
2021
Q3 		$344K Buy
3,192
+38
+1% +$4.34K 0.2% 40
2021
Q2 		$355K Sell
3,154
-187
-6% -$21.1K 0.2% 37
2021
Q1 		$362K Buy
3,341
+1,057
+46% +$113K 0.24% 32
2020
Q4 		$245K Sell
2,284
-53,321
-96% -$5.12M 0.13% 40
2020
Q3 		$4.87M Sell
55,605
-8,433
-13% -$794K 2.47% 14
2020
Q2 		$6.29M Buy
64,038
+439
+0.7% +$38.7K 3.48% 12
2020
Q1 		$4.85M Buy
63,599
+5,624
+10% +$479K 2.89% 12
2019
Q4 		$5.13M Buy
+57,975
New +$4.81M 3.01% 17

Other funds holding ABBV

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Trust Company of Kansas's ABBV Position: Q2 2026 in Review

Trust Company of Kansas increased its AbbVie (ABBV) stake by 12% in Q2 2026, buying an estimated $47.8K and bringing the position to 2,008 shares worth $505K. The position accounts for 0.26% of the portfolio, ranked #30.

Trust Company of Kansas first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $6.29M in Q2 2020. 2,661 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Trust Company of Kansas held 2,008 shares of AbbVie worth $505K as of Q2 2026.
  • Trust Company of Kansas bought 222 AbbVie shares in Q2 2026, an estimated $47.8K.
  • AbbVie made up 0.26% of Trust Company of Kansas's portfolio in Q2 2026, its #30 holding.
  • Trust Company of Kansas first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • Trust Company of Kansas's AbbVie position peaked at $6.29M in Q2 2020.
  • 2,661 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Trust Company of Kansas's 13F filing for Q2 2026, filed 22 Jul 2026.